<p>Legacy Capital Group California Inc. 在最近向证券交易委员会提交的文件中表示，在第三季度购买了 AstraZeneca PLC (NASDAQ:AZN - 免费报告) 的新头寸。该基金购买了 5,287 股公司股票，价值约 406,000 美元。</p>
<ul>
<li>随着投资者逃离美国股票，这只全球 ETF 表现优于大盘</li>
</ul>
<p>其他大型投资者最近也对该公司的头寸进行了调整。Primecap Management Co. CA 在第二季度将其在 AstraZeneca 的持仓增加了 1.3%。Primecap Management Co. CA 目前拥有 41,200,091 股公司股票，价值 2,879,062,000 美元，在上个季度又购买了 538,606 股。Franklin Resources Inc. 在第二季度将其在 AstraZeneca 的持仓提高了 0.9%。Franklin Resources Inc. 目前拥有 21,298,394 股公司股票，价值 1,488,332,000 美元，在上个季度又收购了 196,401 股。Fisher Asset Management LLC 在第三季度将其在 AstraZeneca 的持仓增加了 2.3%。Fisher Asset Management LLC 目前拥有 21,162,724 股公司股票，价值 1,623,604,000 美元，在上个季度又收购了 466,745 股。Dimensional Fund Advisors LP 在第三季度将其在 AstraZeneca 的持仓提高了 9.4%。Dimensional Fund Advisors LP 目前拥有 6,805,896 股公司股票，价值 521,517,000 美元，在上个季度又收购了 582,183 股。最后，Ameriprise Financial Inc. 在第二季度将其在 AstraZeneca 的持仓提高了 2.1%。Ameriprise Financial Inc. 目前拥有 5,046,992 股公司股票，价值 351,734,000 美元，在此期间又购买了 104,625 股。机构投资者持有公司股票的 20.35%。</p>
<h2>AstraZeneca 价格表现</h2>
<p>AZN 的股票在周五开盘价为 194.44 美元。该公司的债务与股本比率为 0.54，速动比率为 0.69，流动比率为 0.88。AstraZeneca PLC 的 12 个月低点为 122.48 美元，12 个月高点为 212.71 美元。该公司的 50 日移动平均价格为 146.71 美元，200 日移动平均价格为 106.43 美元。该公司的市值为 3015.6 亿美元，市盈率为 64.60，市盈增长比率为 1.59，贝塔系数为 0.32。</p>
<h2>AstraZeneca 股息公告</h2>
<ul>
<li>深入了解医疗保健行业的收益：AZN vs. EW vs. ZBH</li>
</ul>
<p>该公司最近还宣布了一项股息，将于 3 月 23 日星期一支付。记录在案的投资者将在 2 月 20 日星期五获得 1.595 美元的股息。这代表了 156.0% 的收益率。除息日期为 2 月 20 日星期五。AstraZeneca 的派息比率为 66.26%。</p>
<h2>分析师设定新目标价</h2>
<p>AZN 最近成为几份分析师报告的主题。巴克莱在 1 月 6 日星期二的研究报告中重申了对 AstraZeneca 股票的 “增持” 评级。摩根士丹利在 12 月 3 日星期三的研究报告中重申了 “增持” 评级，并设定了 103.00 美元的目标价。TD Cowen 在 12 月 9 日星期二的研究报告中重申了对 AstraZeneca 股票的 “买入” 评级。Weiss Ratings 在 1 月 21 日星期三的报告中重申了对 AstraZeneca 股票的 “买入 (b)” 评级。最后，古根海姆在 12 月 3 日星期三的研究报告中重新发布了对 AstraZeneca 的 “买入” 评级。九位股票研究分析师对该股票给予了买入评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该公司的共识评级为 “适度买入”，共识目标价为 95.75 美元。</p>
<ul>
<li>Ozempic、Mounjaro、Wegovy 或 Zepbound？这只 ETF 包含了它们所有</li>
</ul>
<p><strong>查看我们关于 AstraZeneca 的最新研究报告</strong></p>
<h2>AstraZeneca 公司简介</h2>
<p>(免费报告)</p>
<p>AstraZeneca 是一家全球性的、以科学为导向的生物制药公司，总部位于英国剑桥。该公司通过 1999 年瑞典的 Astra AB 和英国的 Zeneca Group 合并而成立，专注于研究、开发、生产和商业化多种治疗领域的处方药。AstraZeneca 的业务涵盖研究与开发、大规模生产和商业分销，在全球发达和新兴市场均有业务。</p>
<p>该公司专注于多个核心治疗领域，包括肿瘤学、心血管、肾脏与代谢 (CVRM)、呼吸与免疫学以及罕见疾病。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 AstraZeneca 更好</li>
<li>“我刚刚购买了 10,000 股一只 5 美元的股票……”</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
<li>摩根大通的 8,000 美元黄金看涨期权将使大多数退休账户落后</li>
<li>白银是新石油——世界正在枯竭</li>
<li>英伟达 CEO 发出大胆的特斯拉看法</li>
</ul>
<p><strong>想看看其他对 AZN 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 AstraZeneca PLC (NASDAQ:AZN - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVpO?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVpO"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 AstraZeneca 吗？</h2>
<p>在考虑 AstraZeneca 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 AstraZeneca 并不在名单上。</p>
<p>虽然 AstraZeneca 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

阿斯利康

<p>Legacy Capital Group California Inc. 在第三季度收购了阿斯利康（AstraZeneca PLC）的新头寸，购买了 5,287 股，价值约为 406,000 美元。其他机构投资者也调整了他们的持股，Primecap Management Co. 增加了 1.3% 的持股，Franklin Resources Inc. 增加了 0.9%。阿斯利康的股票开盘价为 194.44 美元，市值为 3,015.6 亿美元，市盈率为 64.60。该公司最近宣布将于 3 月 23 日支付 1.595 美元的股息，收益率为 156.0%</p>

<p>Legacy Capital Group California Inc. purchased a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The fund purchased 5,287 shares of the company's stock, valued at approximately $406,000.</p>
<div class="lb-trans"><p>Legacy Capital Group California Inc. 在最近向证券交易委员会提交的文件中表示，在第三季度购买了 AstraZeneca PLC (NASDAQ:AZN - 免费报告) 的新头寸。该基金购买了 5,287 股公司股票，价值约 406,000 美元。</p>
</div><ul>
<li>As Investors Flee U.S. Equities, This Global ETF Is Outperforming</li>
</ul>
<div class="lb-trans"><ul>
<li>随着投资者逃离美国股票，这只全球 ETF 表现优于大盘</li>
</ul>
</div><p>Other large investors also recently made changes to their positions in the company. Primecap Management Co. CA grew its position in AstraZeneca by 1.3% in the second quarter. Primecap Management Co. CA now owns 41,200,091 shares of the company's stock worth $2,879,062,000 after buying an additional 538,606 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of AstraZeneca by 0.9% during the 2nd quarter. Franklin Resources Inc. now owns 21,298,394 shares of the company's stock valued at $1,488,332,000 after acquiring an additional 196,401 shares during the last quarter. Fisher Asset Management LLC grew its holdings in shares of AstraZeneca by 2.3% in the 3rd quarter. Fisher Asset Management LLC now owns 21,162,724 shares of the company's stock worth $1,623,604,000 after acquiring an additional 466,745 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of AstraZeneca by 9.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,805,896 shares of the company's stock valued at $521,517,000 after acquiring an additional 582,183 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in AstraZeneca by 2.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,046,992 shares of the company's stock valued at $351,734,000 after purchasing an additional 104,625 shares during the period. Institutional investors own 20.35% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投资者最近也对该公司的头寸进行了调整。Primecap Management Co. CA 在第二季度将其在 AstraZeneca 的持仓增加了 1.3%。Primecap Management Co. CA 目前拥有 41,200,091 股公司股票，价值 2,879,062,000 美元，在上个季度又购买了 538,606 股。Franklin Resources Inc. 在第二季度将其在 AstraZeneca 的持仓提高了 0.9%。Franklin Resources Inc. 目前拥有 21,298,394 股公司股票，价值 1,488,332,000 美元，在上个季度又收购了 196,401 股。Fisher Asset Management LLC 在第三季度将其在 AstraZeneca 的持仓增加了 2.3%。Fisher Asset Management LLC 目前拥有 21,162,724 股公司股票，价值 1,623,604,000 美元，在上个季度又收购了 466,745 股。Dimensional Fund Advisors LP 在第三季度将其在 AstraZeneca 的持仓提高了 9.4%。Dimensional Fund Advisors LP 目前拥有 6,805,896 股公司股票，价值 521,517,000 美元，在上个季度又收购了 582,183 股。最后，Ameriprise Financial Inc. 在第二季度将其在 AstraZeneca 的持仓提高了 2.1%。Ameriprise Financial Inc. 目前拥有 5,046,992 股公司股票，价值 351,734,000 美元，在此期间又购买了 104,625 股。机构投资者持有公司股票的 20.35%。</p>
</div><h2>AstraZeneca Price Performance</h2>
<div class="lb-trans"><h2>AstraZeneca 价格表现</h2>
</div><p>Shares of AZN opened at $194.44 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.69 and a current ratio of 0.88. AstraZeneca PLC has a twelve month low of $122.48 and a twelve month high of $212.71. The firm's 50 day moving average price is $146.71 and its 200 day moving average price is $106.43. The firm has a market cap of $301.56 billion, a PE ratio of 64.60, a PEG ratio of 1.59 and a beta of 0.32.</p>
<div class="lb-trans"><p>AZN 的股票在周五开盘价为 194.44 美元。该公司的债务与股本比率为 0.54，速动比率为 0.69，流动比率为 0.88。AstraZeneca PLC 的 12 个月低点为 122.48 美元，12 个月高点为 212.71 美元。该公司的 50 日移动平均价格为 146.71 美元，200 日移动平均价格为 106.43 美元。该公司的市值为 3015.6 亿美元，市盈率为 64.60，市盈增长比率为 1.59，贝塔系数为 0.32。</p>
</div><h2>AstraZeneca Dividend Announcement</h2>
<div class="lb-trans"><h2>AstraZeneca 股息公告</h2>
</div><ul>
<li>A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH</li>
</ul>
<div class="lb-trans"><ul>
<li>深入了解医疗保健行业的收益：AZN vs. EW vs. ZBH</li>
</ul>
</div><p>The business also recently announced a dividend, which will be paid on Monday, March 23rd. Investors of record on Friday, February 20th will be issued a $1.595 dividend. This represents a yield of 156.0%. The ex-dividend date is Friday, February 20th. AstraZeneca's payout ratio is 66.26%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项股息，将于 3 月 23 日星期一支付。记录在案的投资者将在 2 月 20 日星期五获得 1.595 美元的股息。这代表了 156.0% 的收益率。除息日期为 2 月 20 日星期五。AstraZeneca 的派息比率为 66.26%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>AZN has been the subject of several recent analyst reports. Barclays reaffirmed an &#34;overweight&#34; rating on shares of AstraZeneca in a research report on Tuesday, January 6th. Morgan Stanley restated an &#34;overweight&#34; rating and set a $103.00 price objective on shares of AstraZeneca in a research report on Wednesday, December 3rd. TD Cowen reaffirmed a &#34;buy&#34; rating on shares of AstraZeneca in a research note on Tuesday, December 9th. Weiss Ratings reiterated a &#34;buy (b)&#34; rating on shares of AstraZeneca in a report on Wednesday, January 21st. Finally, Guggenheim reissued a &#34;buy&#34; rating on shares of AstraZeneca in a research report on Wednesday, December 3rd. Nine equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $95.75.</p>
<div class="lb-trans"><p>AZN 最近成为几份分析师报告的主题。巴克莱在 1 月 6 日星期二的研究报告中重申了对 AstraZeneca 股票的 “增持” 评级。摩根士丹利在 12 月 3 日星期三的研究报告中重申了 “增持” 评级，并设定了 103.00 美元的目标价。TD Cowen 在 12 月 9 日星期二的研究报告中重申了对 AstraZeneca 股票的 “买入” 评级。Weiss Ratings 在 1 月 21 日星期三的报告中重申了对 AstraZeneca 股票的 “买入 (b)” 评级。最后，古根海姆在 12 月 3 日星期三的研究报告中重新发布了对 AstraZeneca 的 “买入” 评级。九位股票研究分析师对该股票给予了买入评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该公司的共识评级为 “适度买入”，共识目标价为 95.75 美元。</p>
</div><ul>
<li>Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All</li>
</ul>
<div class="lb-trans"><ul>
<li>Ozempic、Mounjaro、Wegovy 或 Zepbound？这只 ETF 包含了它们所有</li>
</ul>
</div><p><strong>Check Out Our Latest Research Report on AstraZeneca</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 AstraZeneca 的最新研究报告</strong></p>
</div><h2>AstraZeneca Company Profile</h2>
<div class="lb-trans"><h2>AstraZeneca 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>AstraZeneca is a global, science-led biopharmaceutical company headquartered in Cambridge, England. Formed through the 1999 merger of Sweden's Astra AB and the UK's Zeneca Group, the company researches, develops, manufactures and commercializes prescription medicines across a range of therapeutic areas. AstraZeneca's operations span research and development, large-scale manufacturing, and commercial distribution, with a presence in developed and emerging markets worldwide.</p>
<div class="lb-trans"><p>AstraZeneca 是一家全球性的、以科学为导向的生物制药公司，总部位于英国剑桥。该公司通过 1999 年瑞典的 Astra AB 和英国的 Zeneca Group 合并而成立，专注于研究、开发、生产和商业化多种治疗领域的处方药。AstraZeneca 的业务涵盖研究与开发、大规模生产和商业分销，在全球发达和新兴市场均有业务。</p>
</div><p>The company focuses on several core therapy areas including oncology, cardiovascular, renal and metabolism (CVRM), respiratory and immunology, and rare diseases.</p>
<div class="lb-trans"><p>该公司专注于多个核心治疗领域，包括肿瘤学、心血管、肾脏与代谢 (CVRM)、呼吸与免疫学以及罕见疾病。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than AstraZeneca</li>
<li>“I just bought 10,000 shares of a $5 stock…”</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>How JPMorgan's $8,000 Gold Call Will Leave Most Retirement Accounts Behind</li>
<li>Silver Is the New Oil—And the World’s Running Dry</li>
<li>Nvidia CEO Issues Bold Tesla Call</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 AstraZeneca 更好</li>
<li>“我刚刚购买了 10,000 股一只 5 美元的股票……”</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
<li>摩根大通的 8,000 美元黄金看涨期权将使大多数退休账户落后</li>
<li>白银是新石油——世界正在枯竭</li>
<li>英伟达 CEO 发出大胆的特斯拉看法</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding AZN?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AstraZeneca PLC (NASDAQ:AZN - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 AZN 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 AstraZeneca PLC (NASDAQ:AZN - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVpO" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=AZN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in AstraZeneca Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 AstraZeneca 吗？</h2>
</div><p>Before you consider AstraZeneca, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 AstraZeneca 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AstraZeneca wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 AstraZeneca 并不在名单上。</p>
</div><p>While AstraZeneca currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 AstraZeneca 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Legacy Capital Group California Inc. 在阿斯利康公司（AstraZeneca PLC）建立了新的投资头寸